O	0	6	Impact
O	7	9	of
O	10	11	a
B-intervention	12	19	primary
I-intervention	20	24	care
O	25	30	based
O	31	43	intervention
O	44	46	on
O	47	53	breast
O	54	60	cancer
O	61	70	knowledge
O	70	71	,
O	72	76	risk
O	77	87	perception
O	88	91	and
O	92	99	concern
O	99	100	:
O	101	102	A
O	103	113	randomized
O	113	114	,
O	115	125	controlled
O	126	131	trial
O	131	132	.

O	133	135	To
O	136	144	estimate
O	145	148	the
O	149	156	effects
O	157	159	of
O	160	161	a
O	162	168	tablet
O	168	169	-
O	169	174	based
O	174	175	,
O	176	182	breast
O	183	189	cancer
O	190	194	risk
O	195	204	education
O	205	217	intervention
O	218	221	for
O	222	225	use
O	226	228	in
O	229	236	primary
O	237	241	care
O	242	250	settings
O	251	252	(
O	252	262	BreastCARE
O	262	263	)
O	264	266	on
O	267	275	patients
O	275	276	'
O	277	283	breast
O	284	290	cancer
O	291	300	knowledge
O	300	301	,
O	302	306	risk
O	307	317	perception
O	318	321	and
O	322	329	concern
O	329	330	.

O	331	335	From
O	336	340	June
O	341	345	2011
O	345	346	-
O	346	352	August
O	353	357	2012
O	357	358	,
O	359	361	we
O	362	370	enrolled
O	371	376	women
O	377	381	from
O	382	385	two
O	386	393	clinics
O	393	394	,
O	395	399	aged
B-age	400	402	40
I-age	402	403	-
I-age	403	405	74
I-age	406	411	years
B-eligibility	412	416	with
I-eligibility	417	419	no
I-eligibility	420	428	personal
I-eligibility	429	435	breast
I-eligibility	436	442	cancer
I-eligibility	443	450	history
O	450	451	,
O	452	455	and
O	456	466	randomized
O	467	471	them
O	472	474	to
O	475	478	the
O	479	489	BreastCARE
O	490	502	intervention
O	503	508	group
O	509	511	or
O	512	514	to
O	515	518	the
B-control	519	526	control
I-control	527	532	group
O	532	533	.

O	534	537	All
O	538	546	patients
O	547	556	completed
O	557	558	a
O	559	567	baseline
O	568	577	telephone
O	578	584	survey
O	585	588	and
O	589	593	risk
O	594	604	assessment
O	605	606	(
O	606	609	via
O	610	619	telephone
O	620	623	for
O	624	632	controls
O	632	633	,
O	634	637	via
O	638	644	tablet
O	645	653	computer
O	654	656	in
O	657	663	clinic
O	664	671	waiting
O	672	676	room
O	677	682	prior
O	683	685	to
O	686	691	visit
O	692	695	for
O	696	708	intervention
O	708	709	)
O	709	710	.

O	711	714	All
O	715	720	women
O	721	725	were
O	726	737	categorized
O	738	740	as
O	741	745	high
O	746	748	or
O	749	756	average
O	757	761	risk
O	762	767	based
O	768	770	on
O	771	774	the
O	775	783	Referral
O	784	793	Screening
O	794	798	Tool
O	798	799	,
O	800	803	the
O	804	808	Gail
O	809	814	model
O	815	817	or
O	818	821	the
O	822	828	Breast
O	829	835	Cancer
O	836	848	Surveillance
O	849	859	Consortium
O	860	865	model
O	865	866	.

O	867	879	Intervention
O	880	888	patients
O	889	892	and
O	893	898	their
O	899	909	physicians
O	910	918	received
O	919	921	an
O	922	936	individualized
O	937	941	risk
O	942	948	report
O	949	951	to
O	952	959	discuss
O	960	966	during
O	967	970	the
O	971	976	visit
O	976	977	.

O	978	981	All
O	982	987	women
O	988	997	completed
O	998	999	a
O	1000	1006	follow
O	1006	1007	-
O	1007	1009	up
O	1010	1019	telephone
O	1020	1026	survey
O	1027	1028	1
O	1028	1029	-
O	1029	1030	2
O	1031	1036	weeks
O	1037	1042	after
O	1043	1047	risk
O	1048	1058	assessment
O	1058	1059	.

O	1060	1064	Post
O	1064	1065	-
O	1065	1069	test
O	1070	1081	comparisons
O	1082	1091	estimated
O	1092	1103	differences
O	1104	1106	at
O	1107	1113	follow
O	1113	1114	-
O	1114	1116	up
O	1117	1119	in
O	1120	1126	breast
O	1127	1133	cancer
O	1134	1143	knowledge
O	1143	1144	,
O	1145	1149	risk
O	1150	1160	perception
O	1161	1164	and
O	1165	1172	concern
O	1172	1173	.

B-intervention-participants	1174	1177	580
O	1178	1190	intervention
O	1191	1194	and
B-control-participants	1195	1198	655
O	1199	1206	control
O	1207	1212	women
O	1213	1222	completed
O	1223	1229	follow
O	1229	1230	-
O	1230	1232	up
O	1233	1243	interviews
O	1243	1244	.

O	1245	1249	Mean
O	1250	1253	age
O	1254	1257	was
B-age	1258	1260	56
I-age	1261	1266	years
O	1267	1268	(
O	1268	1270	SD
O	1271	1272	=
O	1273	1274	9
O	1274	1275	)
O	1275	1276	.

O	1277	1279	At
O	1280	1286	follow
O	1286	1287	-
O	1287	1289	up
O	1289	1290	,
B-cv-bin-percent	1291	1293	73
I-cv-bin-percent	1293	1294	%
O	1295	1297	of
O	1298	1306	controls
O	1307	1310	and
B-iv-bin-percent	1311	1313	71
I-iv-bin-percent	1313	1314	%
O	1315	1317	of
O	1318	1330	intervention
O	1331	1336	women
B-outcome	1337	1346	correctly
I-outcome	1347	1356	perceived
I-outcome	1357	1362	their
I-outcome	1363	1369	breast
I-outcome	1370	1376	cancer
I-outcome	1377	1381	risk
O	1382	1385	and
B-cv-bin-percent	1386	1388	22
I-cv-bin-percent	1388	1389	%
O	1390	1392	of
O	1393	1401	controls
O	1402	1405	and
B-iv-bin-percent	1406	1408	24
I-iv-bin-percent	1408	1409	%
O	1410	1412	of
O	1413	1425	intervention
O	1426	1431	women
O	1432	1436	were
O	1437	1441	very
B-outcome	1442	1451	concerned
I-outcome	1452	1457	about
I-outcome	1458	1464	breast
I-outcome	1465	1471	cancer
O	1471	1472	.

O	1473	1485	Intervention
O	1486	1494	patients
O	1495	1498	had
O	1499	1506	greater
B-outcome	1507	1516	knowledge
O	1517	1518	(
O	1518	1519	â‰¥
O	1519	1521	75
O	1521	1522	%
O	1523	1530	correct
O	1531	1538	answers
O	1538	1539	)
O	1540	1542	of
O	1543	1549	breast
O	1550	1556	cancer
O	1557	1561	risk
O	1562	1569	factors
O	1570	1572	at
O	1573	1579	follow
O	1579	1580	-
O	1580	1582	up
O	1583	1584	(
B-iv-bin-percent	1584	1586	24
I-iv-bin-percent	1586	1587	%
O	1588	1590	vs
O	1590	1591	.
B-cv-bin-percent	1592	1594	16
I-cv-bin-percent	1594	1595	%
O	1595	1596	;
O	1597	1598	p
O	1599	1600	=
O	1601	1602	0
O	1602	1603	.
O	1603	1606	002
O	1606	1607	)
O	1607	1608	.

O	1609	1611	In
O	1612	1625	multivariable
O	1626	1634	analysis
O	1634	1635	,
O	1636	1641	there
O	1642	1646	were
O	1647	1649	no
O	1650	1661	differences
O	1662	1664	in
O	1665	1672	correct
O	1673	1677	risk
O	1678	1688	perception
O	1689	1691	or
O	1692	1699	concern
O	1699	1700	,
O	1701	1704	but
O	1705	1717	intervention
O	1718	1726	patients
O	1727	1730	had
B-outcome	1731	1738	greater
I-outcome	1739	1748	knowledge
O	1749	1750	(
O	1750	1751	[
O	1751	1753	OR
O	1753	1754	]
O	1755	1756	=
O	1757	1758	1
O	1758	1759	.
O	1759	1761	62
O	1761	1762	;
O	1763	1765	95
O	1765	1766	%
O	1767	1768	[
O	1768	1770	CI
O	1770	1771	]
O	1772	1773	=
O	1774	1775	1
O	1775	1776	.
O	1776	1778	19
O	1778	1779	-
O	1779	1780	2
O	1780	1781	.
O	1781	1783	23
O	1783	1784	)
O	1784	1785	.

O	1786	1787	A
O	1788	1794	simple
O	1794	1795	,
O	1796	1805	practical
O	1806	1818	intervention
O	1819	1828	involving
O	1829	1839	physicians
O	1840	1842	at
O	1843	1846	the
O	1847	1852	point
O	1853	1855	of
O	1856	1860	care
O	1861	1864	can
O	1865	1872	improve
O	1873	1882	knowledge
O	1883	1885	of
O	1886	1892	breast
O	1893	1899	cancer
O	1900	1907	without
O	1908	1918	increasing
O	1919	1926	concern
O	1926	1927	.

O	1928	1942	ClinicalTrials
O	1942	1943	.
O	1943	1946	gov
O	1947	1957	identifier
O	1958	1969	NCT01830933
O	1969	1970	.
